Darunavir Tillomed 600 mg Filmtabletten Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

darunavir tillomed 600 mg filmtabletten

tillomed pharma gmbh (8132043) - darunavir - filmtablette - 600 mg - teil 1 - filmtablette; darunavir (32142) 600 milligramm

Darunavir Vivanta 400 mg Filmtabletten Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

darunavir vivanta 400 mg filmtabletten

vivanta generics s.r.o. (8174834) - darunavir - filmtablette - 400 mg - teil 1 - filmtablette; darunavir (32142) 400 milligramm

Darunavir Vivanta 800 mg Filmtabletten Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

darunavir vivanta 800 mg filmtabletten

vivanta generics s.r.o. (8174834) - darunavir - filmtablette - 800 mg - teil 1 - filmtablette; darunavir (32142) 800 milligramm

Darunavir Viatris 400 mg Tabletten Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

darunavir viatris 400 mg tabletten

viatris pharma gmbh - darunavirum - tabletten - darunavirum 400 mg bis darunavirum ethanolum, excipiens pro compresso dunst. - hiv-infektion - synthetika

Darunavir Viatris 600 mg Tabletten Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

darunavir viatris 600 mg tabletten

viatris pharma gmbh - darunavirum - tabletten - darunavirum 600 mg bis darunavirum ethanolum, excipiens pro compresso dunst. - hiv-infektion - synthetika

Darunavir Viatris 800 mg Tabletten Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

darunavir viatris 800 mg tabletten

viatris pharma gmbh - darunavirum - tabletten - darunavirum 800 mg bis darunavirum ethanolum, excipiens pro compresso dunst. - hiv-infektion - synthetika

Prezista Europäische Union - Deutsch - EMA (European Medicines Agency)

prezista

janssen-cilag international nv - darunavir - hiv-infektionen - antivirale mittel zur systemischen anwendung - prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adult and paediatric patients from the age of 3 years and at least 15 kg body weight. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). in deciding to initiate treatment with prezista co administered with cobicistat or low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista 75 mg, 150 mg, and 600 mg tablets may be used to provide suitable dose regimens:for the treatment of hiv 1 infection in antiretroviral treatment (art) experienced adult patients, including those that have been highly pre treated. for the treatment of hiv 1 infection in paediatric patients from the age of 3 years and at least 15 kg body weight. in deciding to initiate treatment with prezista co administered with low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). prezista 400 mg and 800 mg tablets may be used to provide suitable dose regimens for the treatment of hiv 1 infection in adult and paediatric patients from the age of 3 years and at least 40 kg body weight who are:antiretroviral therapy (art) naïve. art experienced with no darunavir resistance associated mutations (drv rams) and who have plasma hiv 1 rna < 100,000 copies/ml and cd4+ cell count ≥ 100 cells x 106/l. in deciding to initiate treatment with prezista in such art experienced patients, genotypic testing should guide the use of prezista.

Darunasta 800 mg Filmtabletten Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

darunasta 800 mg filmtabletten

tad pharma gmbh (3044021) - darunavir - filmtablette - teil 1 - filmtablette; darunavir (32142) 800 milligramm

Darunasta 400 mg Filmtabletten Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

darunasta 400 mg filmtabletten

tad pharma gmbh (3044021) - darunavir - filmtablette - teil 1 - filmtablette; darunavir (32142) 400 milligramm

Tybost Europäische Union - Deutsch - EMA (European Medicines Agency)

tybost

gilead sciences ireland uc - cobicistat - hiv-infektionen - antivirale mittel zur systemischen anwendung - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.